Showing results (71-80 of 205) with videos related to
Sort By:
Pageof 21
Pharmacoepidemiology and Drug Safety|January 7, 2003
Adverse events in users of sertraline: results from an observational study in psychiatric practice in The NetherlandsWelmoed E E Meijer, Eibert R Heerdink, Jacques ThM van Eijk, et al.Journal of Affective Disorders|March 18, 2008
Changes in outpatient lithium treatment in the Netherlands during 1996-2005I Wilting, P C Souverein, W A Nolen, et al.Orphanet Journal of Rare Diseases|December 17, 2009
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products--a pilot studyPieter Stolk, Harald E Heemstra, Hubert G M Leufkens, et al.Exploratory Research in Clinical and Social Pharmacy|May 8, 2026
Pharmaceutical technical assistants on hospital wards: Qualitative interdisciplinary perspectivesMarjan De Graef, Brecht Serraes, Jolien Heirman, et al.The Annals of Pharmacotherapy|February 27, 2016
Proposal of Standardization to Assess Adherence With Medication Records: Methodology MattersIsabelle Arnet, Marcel J Kooij, Markus Messerli, et al.BMC Endocrine Disorders|December 13, 2019
Effects of the Proactive interdisciplinary self-management (PRISMA) program on self-reported and clinical outcomes in type 2 diabetes: a pragmatic randomized controlled trialEsther du Pon, Nanne Kleefstra, Frits Cleveringa, et al.Therapeutic Advances in Psychopharmacology|July 15, 2021
The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disordersH Abdullah-Koolmees, S Nawzad, T C G Egberts, et al.Journal of Intellectual Disability Research : JIDR|December 16, 2010
Representation of people with intellectual disabilities in randomised controlled trials on antipsychotic treatment for behavioural problemsA Scheifes, J J Stolker, A C G Egberts, et al.Drug Safety|January 26, 2008
Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The NetherlandsDeborah Layton, Patrick C Souverein, Eibert R Heerdink, et al.Pharmacoepidemiology and Drug Safety|September 30, 2008
Prescriber adoption of newly approved selective COX-2 inhibitorsDeborah Layton, Patrick C Souverein, Eibert R Heerdink, et al.Pageof 21